See more : Ardentec Corporation (3264.TWO) Income Statement Analysis – Financial Results
Complete financial analysis of PEXA AB (PEXAB.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PEXA AB, a leading company in the Medical – Specialties industry within the Healthcare sector.
- Scottie Resources Corp. (SCOT.V) Income Statement Analysis – Financial Results
- Shaftesbury PLC (SHABF) Income Statement Analysis – Financial Results
- SecureKloud Technologies Limited (SECURKLOUD.BO) Income Statement Analysis – Financial Results
- AGNC Investment Corp. (AGNCO) Income Statement Analysis – Financial Results
- Beijing Enterprises Water Group Limited (BJWTF) Income Statement Analysis – Financial Results
PEXA AB (PEXAB.ST)
About PEXA AB
Pexa AB engages in the development and commercialization of technology in the field of respiratory medicine. It provides lung researchers with a simple and non-invasive method for collection of microscopic particles, potential biomarkers for diseases in the small airways. The company was founded by Anna-Carin Olin in 2010 and is headquartered in Gothenburg, Sweden.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 6.03M | 2.16M | 673.61K | 1.26M | 2.66M | 1.62M | 2.31M | 361.61K |
| Cost of Revenue | 10.47M | 8.98M | 7.77M | 9.61M | 8.54M | 7.42M | 5.77M | 3.12M |
| Gross Profit | -4.44M | -6.82M | -7.10M | -8.35M | -5.87M | -5.80M | -3.46M | -2.76M |
| Gross Profit Ratio | -73.70% | -315.40% | -1,053.55% | -661.61% | -220.32% | -358.58% | -150.17% | -762.89% |
| Research & Development | 0.00 | 822.14K | 822.15K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | -2.00 | 0.00 | 0.00 | 3.00 | 2.00 | 4.00 | 281.41K | -2.00 |
| Operating Expenses | -2.00 | 822.14K | 822.15K | 3.00 | 2.00 | 4.00 | -281.41K | -2.00 |
| Cost & Expenses | 10.47M | 9.80M | 8.59M | 9.61M | 8.54M | 7.42M | 5.49M | 3.12M |
| Interest Income | 91.29K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 106.00 | 45.00 |
| Interest Expense | 0.00 | 0.00 | 617.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 554.58K | 163.47K | 404.52K | 83.33K | -83.33K | -894.68K | 22.82K | 0.00 |
| EBITDA | -3.75M | -7.60M | -7.51M | -5.92M | -5.79M | -4.91M | -3.16M | -2.76M |
| EBITDA Ratio | -64.50% | -345.87% | -1,115.55% | -655.00% | -217.19% | -303.27% | -137.96% | -762.88% |
| Operating Income | -4.44M | -7.64M | -7.92M | -8.35M | -5.87M | -5.80M | -3.18M | -2.76M |
| Operating Income Ratio | -73.70% | -353.44% | -1,175.60% | -661.61% | -220.32% | -358.58% | -137.97% | -762.89% |
| Total Other Income/Expenses | 136.68K | -119.67K | 6.05K | 2.34M | 13.15K | 310.06K | 22.39K | 92.54K |
| Income Before Tax | -4.31M | -7.76M | -7.91M | -6.01M | -5.86M | -5.49M | -3.16M | -2.67M |
| Income Before Tax Ratio | -71.43% | -358.97% | -1,174.70% | -476.06% | -219.83% | -339.41% | -137.00% | -737.30% |
| Income Tax Expense | -91.30K | -4.00 | -7.00 | 7.00 | 1.00 | 6.00 | 0.00 | 0.00 |
| Net Income | -4.31M | -7.76M | -7.91M | -6.01M | -5.86M | -5.49M | -3.16M | -2.67M |
| Net Income Ratio | -71.43% | -358.97% | -1,174.70% | -476.06% | -219.83% | -339.41% | -137.00% | -737.30% |
| EPS | -0.11 | -0.29 | -0.39 | -0.30 | -0.53 | -0.50 | -0.29 | -0.31 |
| EPS Diluted | -0.11 | -0.29 | -0.39 | -0.30 | -0.53 | -0.50 | -0.29 | -0.31 |
| Weighted Avg Shares Out | 38.28M | 26.68M | 20.28M | 20.28M | 11.00M | 11.00M | 11.00M | 8.65M |
| Weighted Avg Shares Out (Dil) | 38.28M | 26.68M | 20.28M | 20.28M | 11.00M | 11.00M | 11.00M | 8.65M |
Source: https://incomestatements.info
Category: Stock Reports